SynthesisJournal of cancer research and clinical oncology2024

Efficacy of CDK4/6 inhibitors combined with endocrine therapy in HR+/HER2- breast cancer: an umbrella review.

Dongqing Pu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.